Market cap
$63.9M
Shares out
14.2M

Neuraxis Inc. (NRXS) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on AMEX. In the last 30 days Quantisnow tracked 5 wire items for NRXS, including 2 earnings updates, 2 13D/G filings and 1 SEC filing. The most recent was published Nov 16, 2026.

NRXS rankings

Financial highlights

Full financials
Revenue, TTM
$6.53M
Revenue growth
+94.3%
Net income, TTM
-$12.10M
Net margin
-185.2%
Cash
$4.48M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks38-29%
2026-05-24: 02026-05-31: 02026-06-07: 12026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 22026-07-12: 02026-07-19: 12026-07-26: 22026-08-02: 32026-08-09: 22026-08-16: 92026-08-23: 32026-08-30: 02026-09-06: 12026-09-13: 22026-09-20: 02026-09-27: 22026-10-04: 32026-10-11: 22026-10-18: 02026-10-25: 12026-11-01: 02026-11-08: 32026-11-15: 1
2026-05-242026-11-15
Mix1890d
  • Insider7(39%)
  • Other3(17%)
  • Leadership2(11%)
  • SEC Filings2(11%)
  • Earnings2(11%)
  • 13D/G2(11%)
Activity · 52 weeks7041 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

NRXS FAQ

9 questions
  • What is the latest news on NRXS?
    In the last 30 days Quantisnow tracked 5 wire items for NRXS: 2 earnings updates, 2 13D/G filings and 1 SEC filing. The most recent was published on November 16, 2026.
  • What is NRXS revenue?
    Neuraxis Inc. (NRXS) reported $6.53M of revenue for the twelve months ended Sep 30, 2026. That is up 94.3% from the year before. Revenue for fiscal 2025 was $3.57M.
  • Is NRXS profitable?
    No. Neuraxis Inc. reported a net loss of $12.10M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does NRXS have?
    Neuraxis Inc. reported $4.48M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does NRXS stock trade?
    Neuraxis Inc. (NRXS) is listed on AMEX.
  • What sector and industry is NRXS in?
    Neuraxis Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • When did Neuraxis Inc. go public?
    Neuraxis Inc. (NRXS) completed its IPO in 2023.
  • What companies are similar to NRXS?
    Notable peers in the same industry include ITGR (Integer Holdings Corporation), MDT (Medtronic plc.), INMD (InMode Ltd.), AXGN (Axogen Inc.), TMDX (TransMedics Group Inc.). Compare NRXS side-by-side with any of them on Quantisnow.
  • How can I track NRXS on Quantisnow?
    Quantisnow aggregates Neuraxis Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NRXS to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change